_________________________________
Click on the image to open the article in PDF format.
The vaccine industry has been in a difficult situation for a long time. Spending on vaccines is insignificant compared to other interventions. Five multinationals produce 80% of vaccines. There are poor financial returns to the vaccine industry and high production and R&D costs. Manufacturing facilities are capital intensive. Lower-income countries buy vaccines when they are more affordable. Before that, manufacturing costs are covered by vaccine sales in high-income countries.
Click on the image to open the article in PDF format.